Somatostatin and analogues in portal hypertension.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 101 citations in OpenAlex.

1. Timing of endoscopy in patients with acute variceal bleeding in cirrhosis: an updated systematic review and meta-analysis.BMC gastroenterology · 2025
   Pooled it
2. Efficacy of vasopressin/terlipressin and somatostatin/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding: a systematic review and meta-analysis.Hepatology international · 2015
   Pooled it
3. Revision and update on clinical practice guideline for liver cirrhosis.The Korean journal of hepatology · 2012
   Guideline
4. Management of acute esophageal variceal hemorrhage.The Kaohsiung journal of medical sciences · 2010
   Pooled it
5. The small-for-size syndrome in living donor liver transplantation: current management.Updates in surgery · 2025
   Review
6. Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trial.JHEP reports : innovation in hepatology · 2025
   Article
7. Pharmacological Management for Prevention and Treatment of Posthepatectomy Liver Failure.Digestive surgery · 2025
   Review
8. Microarray analysis demonstrates up-regulation of the endothelin-1 gene with compensatory down-regulation of the ETA receptor gene in human portal vein.Bioscience reports · 2024
   Article
9. Emerging Therapeutic Targets for Portal Hypertension.Current hepatology reports · 2023
   Review
10. Short-term vasoactive agent treatment driven by physicians' preference in acute esophageal variceal bleeding in a tertiary center.PeerJ · 2019
    Article
11. Acute variceal bleeding: risk stratification and management (including TIPS).Hepatology international · 2018
    Review
12. Nonendoscopic management strategies for acute esophagogastric variceal bleeding.Gastroenterology clinics of North America · 2014
    Review
13. Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management.World journal of gastroenterology · 2013
    Review
14. Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension.ISRN hepatology · 2013
    Review
15. Use of portal pressure studies in the management of variceal haemorrhage.World journal of gastrointestinal endoscopy · 2012
    Article
16. Acute esophageal variceal bleeding: Current strategies and new perspectives.World journal of hepatology · 2010
    Article
17. Variceal bleeding : pharmacological treatment and prophylactic strategies.Drugs · 2008
    Review
18. The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.Journal of cellular and molecular medicine
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as